FORWARD FEATURES CALENDAR

Intel

CVC sets IPO range at €13-€15

London-based private equity firm CVC Capital Partners has set an initial public offering range of €13 to €15 for its shares, valuing the business at between €13bn and €15bn, with a plan to begin trading on Euronext Amsterdam on Friday.

KKR to acquire disease specialist Immedica Pharma

Investment funds managed by global private investment firm KKR will acquire Immedica Pharma, a Swedish pharmaceutical company focused on the commercialisation of medicines for rare diseases and specialty care products.

Epiris appoints Partner 

London-based private equity firm Epiris has appointed Mike Ebeling as a Partner within its investment team. In his new role, Ebeling will work with the firm’s investment team to deploy Epiris Fund III, which closed in February at £1.044bn.

IK Partners exits Eres Group to Eurazeo 

French private equity firm Eurazeo, through its mid-large buyout team, has agreed to invest in Eres Group and acquire a majority stake from the IK VIII Fund managed by European private equity firm IK Partners, alongside the company’s management team and employees.

Pictet Alternative Advisors launches environmental technology fund 

Pictet Alternative Advisors, the Pictet Group’s alternative investment business, has launched the Pictet Private Assets SICAV – Environment Co-Investment Fund I ELTIF, which is aiming to broaden investor access to environmental technology investments across private markets.

Blackstone trumps Concord with $1.5bn Hipgnosis bid

Private equity giant Blackstone has made an improved offer for Hipgnosis Songs Fund with a proposed $1.5bn deal to acquire the troubled music rights owner, topping a $1.4bn bid made last week by music rights investor Concord, according to a report by Bloomberg.

Events

12 November, 2026 – 5:00 pm

Directory Listings